Adherium Announces Q1 Fiscal Year 2019 Investor Conference Call

SAN MATEO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Tuesday, October 30, 2018 at 6.30pm ET to discuss first quarter fiscal year 2019 results and business update. Arik Anderson, Chief Executive Officer will host the call and will be joined by Adherium’s Chief Financial Officer, David Allinson.

Conference Call details:

Conference ID: 7995294

Dial-in Details:

Webcast:  http://www.openbriefing.com/OB/3099.aspx

For overseas participants, the conference call will commence at:

• 11.30am on Wednesday, October 31, 2018      (New Zealand Standard Time)
• 6.30am on Wednesday, October 31, 2018        (Hong Kong Time)
• 3.30pm on Tuesday, October 30, 2018             (U.S. Pacific Daylight Time)
• 6:30pm on Tuesday, October 30, 2018             (U.S. Eastern Daylight Time)

A recording of the call will be made available in the ‘Investor Centre’ section of the Company website at http://adherium.com/investors/ and at http://www.openbriefing.com/

About Adherium
Based in Silicon Valley, Adherium is a digital health company dedicated to the health and well-being of people with chronic conditions. The company’s pioneering end-to-end hardware and software solution is clinically proven to promote medication adherence. Adherium’s lead product is the FDA-cleared Bluetooth®-enabled Hailie™ solution for the management of respiratory conditions, which has been shown in clinical studies to reduce severe asthma attacks in adults by as much as 60 percent  and reduce hospital admission rates in children by 80 percent.  Additional applications for the company’s platform technologies are in development. Learn more at adherium.com and hailie.com.

Inquiries